{"id":"https://openalex.org/W2890614541","doi":"https://doi.org/10.2217/nnm-2018-0135","title":"Active Natural Oil-Based Nanoemulsion Containing Tacrolimus for Synergistic Antipsoriatic Efficacy","display_name":"Active Natural Oil-Based Nanoemulsion Containing Tacrolimus for Synergistic Antipsoriatic Efficacy","alternate_titles":[],"publication_year":2018,"publication_date":"2018-08-01","ids":{"openalex":"https://openalex.org/W2890614541","doi":"https://doi.org/10.2217/nnm-2018-0135","mag":"2890614541","pmid":"https://pubmed.ncbi.nlm.nih.gov/30188761"},"language":"en","primary_location":{"id":"doi:10.2217/nnm-2018-0135","doi":"https://doi.org/10.2217/nnm-2018-0135","is_oa":false,"landing_page_url":"https://doi.org/10.2217/nnm-2018-0135","pdf_url":null,"source":{"id":"https://openalex.org/S4210216406","display_name":"Nanomedicine","issn_l":"1743-5889","issn":["1743-5889","1748-6963"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310321119","host_organization_name":"Future Medicine","host_organization_lineage":["https://openalex.org/P4310321119"],"host_organization_lineage_names":["Future Medicine"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nanomedicine","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2890614541"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Shivani Sahu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210152674","display_name":"National Institute of Pharmaceutical Education and Research","ror":"https://ror.org/0418yqg16","country_code":"IN","type":"government","lineage":["https://openalex.org/I4210152674"]}],"countries":["IN"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Shivani Sahu","raw_affiliation_strings":["Department of Pharmaceutics, Centre for Pharmaceutical Nanotechnology, National Institute of Pharmaceutical Education & Research, Sector 67 SAS Nagar, Punjab-160 062, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutics, Centre for Pharmaceutical Nanotechnology, National Institute of Pharmaceutical Education & Research, Sector 67 SAS Nagar, Punjab-160 062, India","institution_ids":["https://openalex.org/I4210152674"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046124936","display_name":"Sameer S. Katiyar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210152674","display_name":"National Institute of Pharmaceutical Education and Research","ror":"https://ror.org/0418yqg16","country_code":"IN","type":"government","lineage":["https://openalex.org/I4210152674"]}],"countries":["IN"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Sameer S Katiyar","raw_affiliation_strings":["Department of Pharmaceutics, Centre for Pharmaceutical Nanotechnology, National Institute of Pharmaceutical Education & Research, Sector 67 SAS Nagar, Punjab-160 062, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutics, Centre for Pharmaceutical Nanotechnology, National Institute of Pharmaceutical Education & Research, Sector 67 SAS Nagar, Punjab-160 062, India","institution_ids":["https://openalex.org/I4210152674"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053234794","display_name":"Varun Kushwah","orcid":"https://orcid.org/0000-0002-0636-6674","observed_orcids":["https://orcid.org/0000-0002-0636-6674"]},"institutions":[{"id":"https://openalex.org/I4210152674","display_name":"National Institute of Pharmaceutical Education and Research","ror":"https://ror.org/0418yqg16","country_code":"IN","type":"government","lineage":["https://openalex.org/I4210152674"]}],"countries":["IN"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Varun Kushwah","raw_affiliation_strings":["Department of Pharmaceutics, Centre for Pharmaceutical Nanotechnology, National Institute of Pharmaceutical Education & Research, Sector 67 SAS Nagar, Punjab-160 062, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutics, Centre for Pharmaceutical Nanotechnology, National Institute of Pharmaceutical Education & Research, Sector 67 SAS Nagar, Punjab-160 062, India","institution_ids":["https://openalex.org/I4210152674"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5057122986","display_name":"Sanyog Jain","orcid":"https://orcid.org/0000-0002-0688-9563","observed_orcids":["https://orcid.org/0000-0002-0688-9563","https://orcid.org/0000-0002-6387-1642"]},"institutions":[{"id":"https://openalex.org/I4210152674","display_name":"National Institute of Pharmaceutical Education and Research","ror":"https://ror.org/0418yqg16","country_code":"IN","type":"government","lineage":["https://openalex.org/I4210152674"]}],"countries":["IN"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Sanyog Jain","raw_affiliation_strings":["Department of Pharmaceutics, Centre for Pharmaceutical Nanotechnology, National Institute of Pharmaceutical Education & Research, Sector 67 SAS Nagar, Punjab-160 062, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutics, Centre for Pharmaceutical Nanotechnology, National Institute of Pharmaceutical Education & Research, Sector 67 SAS Nagar, Punjab-160 062, India","institution_ids":["https://openalex.org/I4210152674"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210152674"],"apc_list":null,"apc_paid":null,"fwci":1.8727,"has_fulltext":false,"cited_by_count":74,"citation_normalized_percentile":{"value":0.81467452,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":95,"max":100},"biblio":{"volume":"13","issue":"16","first_page":"1985","last_page":"1998"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10704","display_name":"Advancements in Transdermal Drug Delivery","score":1.0,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10704","display_name":"Advancements in Transdermal Drug Delivery","score":1.0,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tacrolimus","display_name":"tacrolimus","score":0.8579999804496765},{"id":"https://openalex.org/keywords/nanoemulsions","display_name":"nanoemulsions","score":0.8230000138282776},{"id":"https://openalex.org/keywords/psoriasis","display_name":"psoriasis","score":0.8109999895095825},{"id":"https://openalex.org/keywords/topical-drug-delivery","display_name":"topical drug delivery","score":0.7570000290870667},{"id":"https://openalex.org/keywords/nanoemulsion-gel","display_name":"nanoemulsion gel","score":0.9079999923706055},{"id":"https://openalex.org/keywords/dermal-bioavailability","display_name":"dermal bioavailability","score":0.9710000157356262},{"id":"https://openalex.org/keywords/a431-cells","display_name":"A431 cells","score":0.8579999804496765},{"id":"https://openalex.org/keywords/serum-cytokines","display_name":"serum cytokines","score":0.9539999961853027},{"id":"https://openalex.org/keywords/sustained-release","display_name":"sustained drug release","score":0.5099999904632568}],"concepts":[{"id":"https://openalex.org/C2909675724","wikidata":"https://www.wikidata.org/wiki/Q411648","display_name":"Tacrolimus","level":3,"score":0.7518848180770874},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5226411819458008},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.37783026695251465},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.26467323303222656},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.06407815217971802},{"id":"https://openalex.org/C2911091166","wikidata":"https://www.wikidata.org/wiki/Q106419912","display_name":"Transplantation","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000279","descriptor_name":"Administration, Cutaneous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004655","descriptor_name":"Emulsions","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011565","descriptor_name":"Psoriasis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012869","descriptor_name":"Skin Absorption","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016559","descriptor_name":"Tacrolimus","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D016559","descriptor_name":"Tacrolimus","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016559","descriptor_name":"Tacrolimus","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053758","descriptor_name":"Nanoparticles","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.2217/nnm-2018-0135","doi":"https://doi.org/10.2217/nnm-2018-0135","is_oa":false,"landing_page_url":"https://doi.org/10.2217/nnm-2018-0135","pdf_url":null,"source":{"id":"https://openalex.org/S4210216406","display_name":"Nanomedicine","issn_l":"1743-5889","issn":["1743-5889","1748-6963"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310321119","host_organization_name":"Future Medicine","host_organization_lineage":["https://openalex.org/P4310321119"],"host_organization_lineage_names":["Future Medicine"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nanomedicine","raw_type":"journal-article"},{"id":"pmid:30188761","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30188761","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nanomedicine (London, England)","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9763000011444092}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":31,"referenced_works":["https://openalex.org/W325982514","https://openalex.org/W1521483346","https://openalex.org/W1939997832","https://openalex.org/W1963918885","https://openalex.org/W1966214888","https://openalex.org/W1973302470","https://openalex.org/W2010708477","https://openalex.org/W2021868218","https://openalex.org/W2043430114","https://openalex.org/W2052939506","https://openalex.org/W2058499083","https://openalex.org/W2059095993","https://openalex.org/W2068325918","https://openalex.org/W2074718848","https://openalex.org/W2079621764","https://openalex.org/W2080090843","https://openalex.org/W2089257120","https://openalex.org/W2106531760","https://openalex.org/W2110929416","https://openalex.org/W2121126920","https://openalex.org/W2136734135","https://openalex.org/W2144523920","https://openalex.org/W2154862932","https://openalex.org/W2231208915","https://openalex.org/W2474977933","https://openalex.org/W2555371277","https://openalex.org/W2592887549","https://openalex.org/W2606421759","https://openalex.org/W2653281496","https://openalex.org/W2756279074","https://openalex.org/W4231446881"],"related_works":["https://openalex.org/W3134353638","https://openalex.org/W2231208915","https://openalex.org/W4379207527","https://openalex.org/W4402534946","https://openalex.org/W2592887549","https://openalex.org/W3089333845","https://openalex.org/W3087460734","https://openalex.org/W4395663260","https://openalex.org/W4399916006","https://openalex.org/W4364381179"],"abstract_inverted_index":{"AIM:":[0],"The":[1,84],"current":[2],"study":[3],"is":[4],"emphasized":[5],"on":[6,62],"development":[7],"of":[8],"a":[9,36],"nanoemulsion":[10,30,37,85],"system":[11],"that":[12],"simultaneously":[13],"delivers":[14],"two":[15],"antipsoriatic":[16],"agents":[17],"viz.":[18],"Tacrolimus":[19],"and":[20,46,54,110],"Kalonji":[21],"oil":[22],"(functional":[23],"excepient)":[24],"topically.":[25],"MATERIALS":[26],"&":[27],"METHODS:":[28],"A":[29,104],"was":[31,39,60,115],"characterized":[32],"for":[33,41,141],"quality":[34],"attributes;":[35],"gel":[38,86,135],"evaluated":[40,61],"spreadability,":[42],"viscosity,":[43],"dermal":[44],"bioavailability,":[45],"in":[47,50,65,101,107,112,117],"vitro":[48,102],"efficacy":[49,121],"A-431":[51],"cell":[52],"line,":[53],"so":[55],"forth.":[56],"In":[57],"vivo":[58],"performance":[59],"psoriasis":[63,142],"model":[64],"BALB/c":[66],"mice.":[67],"RESULTS:":[68],"Nanoemulsion":[69,134],"depicted":[70],"droplet":[71],"size:":[72],"93.37":[73],"\u00b1":[74,82],"2.58":[75],"nm":[76],"with":[77,90,123],"PDI":[78],"(Polydispersity":[79],"Index)":[80],"0.330":[81],"0.025.":[83],"exhibited":[87],"desirable":[88],"spreadability":[89],"sustained":[91],"release":[92],"pattern":[93],"(biphasic).":[94],"Dermal":[95],"bioavailability":[96],"enhancement":[97],"(4.33-fold)":[98],"accompanied":[99],"significant":[100,105],"results.":[103],"reduction":[106],"serum":[108],"cytokines":[109],"improvement":[111],"psoriatic":[113],"condition":[114],"achieved":[116],"vivo,":[118],"indicating":[119],"formulation":[120,125],"compared":[122],"marketed":[124],"(Tacroz":[126],"Forte,":[127],"Glenmark":[128],"Pharmaceuticals":[129],"Ltd,":[130],"Maharashtra,":[131],"India).":[132],"CONCLUSION:":[133],"thus":[136],"provides":[137],"an":[138],"effective":[139],"alternative":[140],"treatment.":[143]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2890614541","counts_by_year":[{"year":2026,"cited_by_count":16},{"year":2025,"cited_by_count":7},{"year":2024,"cited_by_count":12},{"year":2023,"cited_by_count":11},{"year":2022,"cited_by_count":12},{"year":2021,"cited_by_count":8},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":3}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2018-09-27T00:00:00"}
